Obesity
Conditions
Interventions
Experimental group: 75 adolescents with obesity will receive supplementation of 30g of cashew nuts a day and nutritional guidelines based on the Food Guide for the Brazilian Population with a focus on
Sponsors
Universidade Estadual do Ceará - UECE
Universidade Estadual do Ceará - UECE
Eligibility
Age
10 Years to 17 Years
Inclusion criteria
Inclusion criteria: Adolescents from 10 to 17 years old from public schools in the municipal education network of Fortaleza; diagnosed with obesity based on the values ??of Body Mass Index (BMI) for age in z score of the World Health Organization (WHO, 2000)
Exclusion criteria
Exclusion criteria: Individuals who have any allergy or intolerance to cashew nuts; who have type 1 diabetes; who are using any vitamin or mineral supplement; who have started any treatment or follow up aimed at losing weight
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main primary outcome is the reduction in central adiposity, verified by measuring neck circumference, with a variation of at least 5% between the measurements before and after the intervention.;Abdominal and total fat reduction, verified through waist circumference, with a variation of at least 5% between the measurements before and after the intervention.;Reduction of body fat percentage, using the bioelectrical impedance method, with a variation of at least 5% between the measurements before and after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| The main secondary outcome is the improvement of health status, verified by the reduction of low-density lipoprotein (LDL) plasma concentrations, from an automatic biochemical analyzer with commercial kits, with a variation of at least 5% between the measurements before and after the intervention.;Reduction of plasma concentrations of total cholesterol, from an automatic biochemical analyzer with commercial kits, with a variation of at least 5% between the measurements before and after the intervention.;Reduction of plasma concentrations of triglycerides, from an automatic biochemical analyzer with commercial kits, with a variation of at least 5% between the measurements before and after the intervention.;Reduction of plasma glucose concentrations, from an automatic biochemical analyzer with commercial kits, with a variation of at least 5% between the measurements before and after the intervention.;Increase in plasma concentrations of high-density lipoprotein (HDL) from an automated biochemical analyzer with commercial kits, with a variation of at least 5% between the measurements before and after the intervention. | — |
Countries
Brazil
Contacts
Public ContactCarla Maia
Universidade Estadual do Ceará - UECE
Outcome results
None listed